Yoshio Tsujita

3.3k total citations · 1 hit paper
54 papers, 2.7k citations indexed

About

Yoshio Tsujita is a scholar working on Molecular Biology, Surgery and Biotechnology. According to data from OpenAlex, Yoshio Tsujita has authored 54 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 26 papers in Surgery and 21 papers in Biotechnology. Recurrent topics in Yoshio Tsujita's work include Lipoproteins and Cardiovascular Health (18 papers), Plant biochemistry and biosynthesis (18 papers) and Microbial Metabolism and Applications (15 papers). Yoshio Tsujita is often cited by papers focused on Lipoproteins and Cardiovascular Health (18 papers), Plant biochemistry and biosynthesis (18 papers) and Microbial Metabolism and Applications (15 papers). Yoshio Tsujita collaborates with scholars based in Japan, United States and Germany. Yoshio Tsujita's co-authors include Masao Kuroda, Akira Endo, Kazuhiko Tanzawa, Yoko Shimada, MAMORU ARAI, Yoshio Watanabe, Masao Kuroda, Masaharu Fukami, Takashi Ito and Junichiro Fukushige and has published in prestigious journals such as Journal of the American College of Cardiology, Applied and Environmental Microbiology and Biochemical and Biophysical Research Communications.

In The Last Decade

Yoshio Tsujita

51 papers receiving 2.4k citations

Hit Papers

ML-236A, ML-236B, and ML-236C, new inhibitors of choleste... 1976 2026 1992 2009 1976 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.
    1976 708 citations Akira Endo, Masao Kuroda et al. The Journal of Antibiotics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshio Tsujita Japan 22 1.3k 1.1k 772 658 316 54 2.7k
Jesse W. Huff United States 17 1.7k 1.3× 569 0.5× 834 1.1× 706 1.1× 164 0.5× 31 3.1k
V. M. Hunt United States 8 991 0.8× 467 0.4× 779 1.0× 597 0.9× 112 0.4× 9 1.7k
Roger S. Newton United States 43 1.8k 1.4× 2.9k 2.5× 144 0.2× 765 1.2× 895 2.8× 92 6.5k
D W Bilheimer United States 10 592 0.5× 1.1k 0.9× 190 0.2× 106 0.2× 430 1.4× 10 1.7k
Ishaiahu Shechter United States 30 1.6k 1.3× 951 0.8× 77 0.1× 154 0.2× 553 1.8× 66 3.0k
Heyao Wang China 30 1.2k 0.9× 359 0.3× 101 0.1× 327 0.5× 163 0.5× 111 2.4k
G. W. Kuron United States 8 859 0.7× 376 0.3× 720 0.9× 553 0.8× 88 0.3× 12 1.5k
Shuyi Si China 29 1.9k 1.4× 613 0.5× 85 0.1× 1.3k 1.9× 477 1.5× 86 3.5k
Cecilia Hoffman United States 5 812 0.6× 291 0.3× 706 0.9× 537 0.8× 81 0.3× 7 1.4k
Hideaki Moriwaki Japan 16 593 0.5× 488 0.4× 149 0.2× 422 0.6× 224 0.7× 24 2.8k

Countries citing papers authored by Yoshio Tsujita

Since Specialization
Citations

This map shows the geographic impact of Yoshio Tsujita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshio Tsujita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshio Tsujita more than expected).

Fields of papers citing papers by Yoshio Tsujita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshio Tsujita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshio Tsujita. The network helps show where Yoshio Tsujita may publish in the future.

Co-authorship network of co-authors of Yoshio Tsujita

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshio Tsujita. A scholar is included among the top collaborators of Yoshio Tsujita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshio Tsujita. Yoshio Tsujita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shiomi, Masashi, Takashi Ito, Toyohiro Tsukada, Yoshio Tsujita, & Hiroyoshi Horikoshi. (1999). Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits. Atherosclerosis. 142(2). 345–353. 52 indexed citations
3.
Tanimoto, Tatsuo, Satoshi Ohya, & Yoshio Tsujita. (1998). Inhibitory Activity to Protein Prenylation and Antifungal Activity of Zaragozic Acid D3, a Potent Inhibitor of Squalene Synthase Produced by the Fungus, Mollisia sp. SANK 10294.. The Journal of Antibiotics. 51(4). 428–431. 8 indexed citations
4.
Ou, Jiafu, Shiro Jimi, Takao Ohta, et al.. (1998). Mechanism of action of probucol on cholesteryl ester transfer protein (CETP) mRNA in a Chinese hamster ovary cell line that had been stably transfected with a human CETP gene. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1393(1). 153–160. 11 indexed citations
5.
Tamaki, Shinji, et al.. (1998). Polymorphism of α-adducin and hypertension. Journal of the American College of Cardiology. 31. 443–443. 1 indexed citations
6.
Fujioka, Tomoyuki, Yoshio Tsujita, & Hidenori Shimotsu. (1997). Induction of fatty acid synthesis by pravastatin sodium in rat liver and primary hepatocytes. European Journal of Pharmacology. 328(2-3). 235–239. 9 indexed citations
7.
Fujioka, Tomoyuki, KIYOSHI HAMANO, Tsuyoshi Hosoya, et al.. (1996). Epi-cochlioquinone A, a Novel Acyl-CoA: Cholesterol Acyltransferase Inhibitor Produced by Stachybotrys bisbyi.. The Journal of Antibiotics. 49(5). 409–413. 32 indexed citations
8.
Tanimoto, Tatsuo, Tsuyoshi Hosoya, YASUYUKI TAKAMATSU, et al.. (1996). Schizostatin, a Novel Squalene Synthase Inhibitor Produced by the Mushroom, Schizophyllum commune. I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities.. The Journal of Antibiotics. 49(7). 617–623. 25 indexed citations
9.
Fujioka, Tomoyuki, Futoshi Nara, Yoshio Tsujita, et al.. (1995). The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1254(1). 7–12. 87 indexed citations
10.
Shimada, Yoko, Tomoko Ogawa, Aiya Sato, Isao Kaneko, & Yoshio Tsujita. (1995). Induction of Differentiation of HL-60 Cells by the Anti-fungal Antibiotic, Radicicol.. The Journal of Antibiotics. 48(8). 824–830. 19 indexed citations
11.
Tsujita, Yoshio. (1994). HMG-CoA reductase inhibitors as potent cholesterol lowering drugs. 2 indexed citations
12.
Tsujita, Yoshio. (1993). DISCOVERY AND DEVELOPMENT OF HYPOLIPIDEMIC DRUG, PRAVASTATIN SODIUM. Medical Entomology and Zoology. 12(4). 279–289. 1 indexed citations
13.
Kuroda, Masao, Akiyo Matsumoto, Hiroshige Itakura, et al.. (1992). Effects of Pravastatin Sodium Alone and in Combination with Cholestyramine on Hepatic, Intestinal and Adrenal Low Density Lipoprotein Receptors in Homozygous Watanabe Heritable Hyperlipidemic Rabbits. The Japanese Journal of Pharmacology. 59(1). 65–70. 15 indexed citations
14.
KISHIDA, Y., et al.. (1991). Research and Development of Pravastatin. YAKUGAKU ZASSHI. 111(9). 469–487. 11 indexed citations
15.
Tsujita, Yoshio. (1990). HMG-CoA Reductase Inhibitors. The Journal of Japan Atherosclerosis Society. 18(2). 165–171. 1 indexed citations
16.
Tsujita, Yoshio. (1990). A potent HMG-CoA reductase inhibitor, pravastatin sodium-tissue-selective inhibition of cholesterogenesis and preventive effect on atherosclerosis in WHHL rabbits. 3(1). 155–159.
17.
Fujii, Setsuro, MAMORU ARAI, Yoshio Tsujita, & Minoru Tanaka. (1985). An Inhibitor of Cholesterol Synthesis. Journal of Atherosclerosis and Thrombosis. 13(2). 251–258. 6 indexed citations
18.
Serizawa, Nobufusa, Keiko Nakagawa, Yoshio Tsujita, & Akira Terahara. (1984). Microbial transformation of ML-236B (compactin) to M3, a mammalian metabolite of ML-236B.. Agricultural and Biological Chemistry. 48(10). 2581–2582. 1 indexed citations
19.
Tsujita, Yoshio & Akira Endo. (1980). Intracellular localization of two molecular forms of membrane acid protease in Aspergillus oryzae.. PubMed. 88(1). 113–20. 8 indexed citations
20.
Tsujita, Yoshio & Akira Endo. (1978). Purification and Characterization of the Two Molecular Forms of Membrane Acid Protease from Aspergillus oryzae. European Journal of Biochemistry. 84(2). 347–353. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jesse W. Huff Breakdown of academic impact, for papers by V. M. Hunt Breakdown of academic impact, for papers by Roger S. Newton Breakdown of academic impact, for papers by D W Bilheimer Breakdown of academic impact, for papers by Ishaiahu Shechter Breakdown of academic impact, for papers by Heyao Wang Breakdown of academic impact, for papers by G. W. Kuron Breakdown of academic impact, for papers by Shuyi Si Breakdown of academic impact, for papers by Cecilia Hoffman Breakdown of academic impact, for papers by Hideaki Moriwaki
Rankless by CCL
2026